Vir Biotechnology Inc (VIR)
9.31
-0.06
(-0.64%)
USD |
NASDAQ |
Nov 05, 09:33
Vir Biotechnology Price: 9.31 for Nov. 5, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 9.26 | 9.505 | 9.025 | 9.37 | 1.544M |
| Nov 01, 2024 | 7.14 | 9.74 | 7.12 | 9.26 | 7.289M |
| Oct 31, 2024 | 7.65 | 7.66 | 7.45 | 7.49 | 1.274M |
| Oct 30, 2024 | 7.55 | 7.82 | 7.53 | 7.60 | 802362.0 |
| Oct 29, 2024 | 7.75 | 7.78 | 7.56 | 7.61 | 782124.0 |
| Oct 28, 2024 | 7.57 | 7.92 | 7.50 | 7.75 | 1.904M |
| Oct 25, 2024 | 7.36 | 7.755 | 7.36 | 7.48 | 1.111M |
| Oct 24, 2024 | 7.52 | 7.525 | 7.24 | 7.35 | 732614.0 |
| Oct 23, 2024 | 7.59 | 7.68 | 7.495 | 7.52 | 851541.0 |
| Oct 22, 2024 | 7.62 | 7.69 | 7.478 | 7.61 | 623284.0 |
| Oct 21, 2024 | 7.62 | 7.76 | 7.57 | 7.65 | 747332.0 |
| Oct 18, 2024 | 7.75 | 7.80 | 7.560 | 7.63 | 451390.0 |
| Oct 17, 2024 | 7.87 | 7.900 | 7.70 | 7.72 | 741690.0 |
| Oct 16, 2024 | 7.76 | 7.935 | 7.66 | 7.87 | 817691.0 |
| Oct 15, 2024 | 7.60 | 7.79 | 7.535 | 7.75 | 754435.0 |
| Oct 14, 2024 | 7.54 | 7.77 | 7.54 | 7.67 | 545295.0 |
| Oct 11, 2024 | 7.34 | 7.64 | 7.31 | 7.59 | 689067.0 |
| Oct 10, 2024 | 7.24 | 7.44 | 7.20 | 7.34 | 589834.0 |
| Oct 09, 2024 | 7.30 | 7.42 | 7.20 | 7.33 | 523237.0 |
| Oct 08, 2024 | 7.41 | 7.44 | 7.26 | 7.32 | 564494.0 |
| Oct 07, 2024 | 7.65 | 7.79 | 7.29 | 7.40 | 530475.0 |
| Oct 04, 2024 | 7.44 | 7.76 | 7.385 | 7.74 | 836339.0 |
| Oct 03, 2024 | 7.59 | 7.66 | 7.315 | 7.33 | 661322.0 |
| Oct 02, 2024 | 7.52 | 7.79 | 7.33 | 7.68 | 695045.0 |
| Oct 01, 2024 | 7.44 | 7.57 | 7.12 | 7.56 | 1.088M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
7.26
Minimum
Sep 25 2024
83.07
Maximum
Jan 27 2021
26.69
Average
25.62
Median
Dec 06 2022
Price Benchmarks
| Pfizer Inc | 27.64 |
| Biomarin Pharmaceutical Inc | 65.80 |
| Arbutus Biopharma Corp | 3.85 |
| GlycoMimetics Inc | 0.40 |
| FibroGen Inc | 0.324 |
Price Related Metrics
| PS Ratio | 20.36 |
| Price to Book Value | 1.026 |
| Earnings Yield | -42.11% |
| Market Cap | 1.273B |